Pancreatic Cancer Research

ResearcherSeoul National UniversityActive in the last 2 years

Jae Young Lee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6946-6042; OpenAlex author ID A5009726724, A5100350932, A5135244841. Sources: OpenAlex.

Their work

Papers
12 (first author 5, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
33
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 2 papers · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 3 papers

Papers 12

  1. Non-thermal focused ultrasound with FOLFIRINOX for borderline resectable or locally advanced pancreatic cancer: An explorative phase II trial. First author DOI 10.1016/j.ejca.2026.116903↗
  2. Focused ultrasound as a therapeutic adjunct in pancreatic cancer: from thermal and mechanical effects to immune modulation. Co-author DOI 10.14366/usg.25199↗
  3. Non-ablative focused ultrasound induces an adaptive immune response to suppress pancreatic cancer: a preclinical study. Last author DOI 10.14366/usg.25228↗
  4. Modulation of cell viability, apoptosis, and autophagy in pancreatic cancer cells using therapeutic ultrasound with microbubbles and gemcitabine. First author DOI 10.14366/usg.25084↗
  5. Combination of chemotherapy and focused ultrasound for the treatment of unresectable pancreatic cancer: a proof-of-concept study. Co-author DOI 10.1007/s00330-022-09271-8↗
  6. Synergistic Effects of Pulsed Focused Ultrasound and a Doxorubicin-Loaded Microparticle-Microbubble Complex in a Pancreatic Cancer Xenograft Mouse Model. First author DOI 10.1016/j.ultrasmedbio.2020.07.019↗
  7. In vivo study of enhanced chemotherapy combined with ultrasound image-guided focused ultrasound (USgFUS) treatment for pancreatic cancer in a xenograft mouse m… Last author DOI 10.1007/s00330-018-5355-9↗
  8. Therapeutic Effects of Microbubbles Added to Combined High-Intensity Focused Ultrasound and Chemotherapy in a Pancreatic Cancer Xenograft Model. First author DOI 10.3348/kjr.2016.17.5.779↗
  9. Dynamic contrast-enhanced ultrasonographic (DCE-US) assessment of the early response after combined gemcitabine and HIFU with low-power treatment for the mouse… Co-author DOI 10.1007/s00330-014-3260-4↗
  10. Pulsed high-intensity focused ultrasound enhances apoptosis of pancreatic cancer xenograft with gemcitabine. First author DOI 10.1016/j.ultrasmedbio.2013.06.004↗
  11. Diagnostic performance of MDCT for predicting important prognostic factors in pancreatic cancer. Co-author DOI 10.1097/mpa.0b013e318287c604↗
  12. Concurrent chemotherapy and pulsed high-intensity focused ultrasound therapy for the treatment of unresectable pancreatic cancer: initial experiences. Co-author DOI 10.3348/kjr.2011.12.2.176↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eun-Joo Park · 5 shared papers, 2016–2026 · strength 1.08
  2. Yun Deok Ahn · 4 shared papers, 2018–2026 · strength 1.01
  3. Sang Hyub Lee · 2 shared papers, 2023–2026 · strength 0.51
  4. Joon Koo Han · 6 shared papers, 2011–2020 · strength 0.34
  5. Seunghyeon Roh · 1 shared paper, 2025 · strength 0.33
  6. Jin‐Young Jang · 1 shared paper, 2026 · strength 0.32
  7. Dong Ho Lee · 1 shared paper, 2026 · strength 0.32
  8. Woo Hyun Paik · 1 shared paper, 2026 · strength 0.32
  9. In Rae Cho · 1 shared paper, 2026 · strength 0.32
  10. Wooil Kwon · 1 shared paper, 2026 · strength 0.32
  11. Chrit T. W. Moonen · 1 shared paper, 2026 · strength 0.29
  12. Timothy N. J. Bullock · 1 shared paper, 2026 · strength 0.29
  13. Joan Vidal-Jové · 1 shared paper, 2026 · strength 0.29
  14. Holger Grüll · 1 shared paper, 2026 · strength 0.29
  15. Petros Mouratidis · 1 shared paper, 2026 · strength 0.29
  16. Cyril Lafon · 1 shared paper, 2026 · strength 0.29
  17. Dong Ho Lee · 1 shared paper, 2023 · strength 0.19
  18. Kyung-Hun Lee · 1 shared paper, 2023 · strength 0.19
  19. Dong‐Hyuk Park · 1 shared paper, 2023 · strength 0.19
  20. Do‐Youn Oh · 1 shared paper, 2023 · strength 0.19
  21. Hyo‐Jin Kang · 1 shared paper, 2020 · strength 0.12
  22. Hak Jong Lee · 1 shared paper, 2020 · strength 0.12
  23. Byung Ihn Choi · 2 shared papers, 2013–2016 · strength 0.10
  24. Jung Hoon Kim · 2 shared papers, 2013–2014 · strength 0.09
  25. Byung Ihn Choi · 2 shared papers, 2011–2013 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.